Opko Health inks $295M deal with Pfizer

Home › Opko Health inks $295M deal with Pfizer

Miami-based Opko Health will receive at least $295 million from Pfizer to develop Opko's growth hormone deficiency treatment.

23.09	Price Ranch earns RAAA 2024 Commercial Producer of the Year
23.09	Tropical Storm John Update Statement
23.09	Summary for Tropical Storm John (EP5/EP102024)
23.09	Is the Budget's bite going to be rather less painful than its bark?
23.09	Flushability Standard Introduced in China
23.09	Union boss questions Amazon public contracts
23.09	Texas Landowners Advocate for Major Changes to Oilfield Waste Disposal Procedures
23.09	Long Islands Waste Future Uncertain as Landfill Closure Looms
More »

je.st